Purdue Pharma pleads guilty to criminal charges over opioids
Reports have said that Purdue Pharma has pleaded guilty to three criminal charges over issues regarding its opioid painkiller, OxyContin.
List view / Grid view
Reports have said that Purdue Pharma has pleaded guilty to three criminal charges over issues regarding its opioid painkiller, OxyContin.
PhRMA and other organisations have challenged action by the HHS and FDA that permits the importation of drugs from Canada without drug manufacturers’ oversight.
According to the BIA, less than four percent of eligible projects received funding from a government programme for early-stage biotech companies.
Report reveals global pharma supply chain leaders are afraid of the vulnerabilities in the end-to-end supply chain as the COVID-19 pandemic continues.
Mary Alice Dwyer and Sameer Lal explain how pharmaceutical companies can embrace a more customer-centric approach through digital transformation.
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
Rising at a CAGR of 4.5 percent, the lateral flow assays market is projected increase due to the high prevalence of infectious diseases worldwide.
New principles on diversity in clinical trials in the US have been released to address systemic issues that deter people from participating in studies.
A new analysis suggests that Europe and North America will capture more than 80 percent of the $9.3 billion market by 2030.
This article explores how COVID-19 has impacted clinical investigation sites and what companies could do to mitigate the effect on trials moving forwards.
Following approval by Emisphere shareholders, Novo Nordisk will acquire the company for a total of $1.8 billion.
The FDA has given Fast Track Designation to NVX-CoV2373, Novavax’s COVID-19 vaccine candidate, created using recombinant nanoparticle technology.
A new report has found that if COVID-19 biologics are approved, it could apply pressure to the global biomanufacturing capacity.
A report has found that the biggest hurdle for digital transformation in pharma is a lack of specific skills and talents, followed by organisational silos.
According to the developers of a new paper tube-pouch, its design could reduce plastic use by up to 65 percent in pharma packaging.